Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2022

Su M, Page S, Haag M, Swisshelm K, Hennerich D, Graw S, et al. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center. J Genet Couns. 2022;31(2):364-374.

Berchuck JE, Adib E, Alaiwi SA, Dash AK, Shin JN, Lowder D, et al. The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response. Cancer Res. 2022;82(16):2848-2859.

Jang J-, Hwang I, Pan H, Yao J, Alinari L, Imada E, et al. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas. J Clin Invest. 2022;132(24).

Burnham P, Chen F, Cheng AP, Srivatana V, Zhang LT, Edusei E, et al. Peritoneal Effluent Cell-Free DNA Sequencing in Peritoneal Dialysis Patients With and Without Peritonitis. Kidney Med. 2022;4(1):100383.

Vyas M, Hissong E, Gonzalez RS, Shia J, Jessurun J. Metastatic Neoplasms Involving the Stomach. Am J Clin Pathol. 2022;157(6):863-873.

Boyraz B, Agarwal S, Pratt DS, Simoneau T, Bhan I, Markmann JF, et al. Hepatic vascular remodelling in a patient with dyskeratosis congenita. Histopathology. 2022;80(2):450-453.

Suryawanshi H, Yang H, Lubetzky M, Morozov P, Lagman M, Thareja G, et al. Detection of infiltrating fibroblasts by single-cell transcriptomics in human kidney allografts. PLoS One. 2022;17(6):e0267704.

Chen J, San SS, Kung A, Tomasek M, Liu D, Rodgers W, et al. Direct-from-specimen microbial growth inhibition spectrums under antibiotic exposure and comparison to conventional antimicrobial susceptibility testing. PLoS One. 2022;17(2):e0263868.

Orea-Soufi A, Paik J, Bragança J, Donlon TA, Willcox BJ, Link W. FOXO transcription factors as therapeutic targets in human diseases. Trends Pharmacol Sci. 2022;43(12):1070-1084.

van der Mijn JC, Eng KW, Chandra P, Fernandez E, Ramazanoglu S, Sigaras A, et al. The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy. Mol Oncol. 2022;16(12):2384-2395.